NRx Pharmaceuticals Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for NRx Pharmaceuticals.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth | 21.1% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 19 Jan 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | N/A | N/A | N/A | -26 | 2 |
12/31/2023 | N/A | -30 | -22 | -22 | N/A |
9/30/2023 | N/A | -36 | -27 | -27 | N/A |
6/30/2023 | N/A | -39 | -28 | -28 | N/A |
3/31/2023 | N/A | -37 | -35 | -35 | N/A |
12/31/2022 | N/A | -40 | -40 | -40 | N/A |
9/30/2022 | N/A | -60 | -43 | -43 | N/A |
6/30/2022 | N/A | -88 | -48 | -48 | N/A |
3/31/2022 | N/A | -81 | -45 | -45 | N/A |
12/31/2021 | N/A | -93 | -38 | -38 | N/A |
9/30/2021 | N/A | -108 | -27 | -27 | N/A |
6/30/2021 | N/A | -76 | -16 | -16 | N/A |
3/31/2021 | N/A | -76 | -4 | -4 | N/A |
12/31/2020 | N/A | -52 | -2 | -2 | N/A |
9/30/2020 | N/A | -8 | -3 | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if NRXP's forecast earnings growth is above the savings rate (2.3%).
Earnings vs Market: Insufficient data to determine if NRXP's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if NRXP's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if NRXP's revenue is forecast to grow faster than the US market.
High Growth Revenue: NRXP is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NRXP's Return on Equity is forecast to be high in 3 years time